NCAM1 and thyroid gland carcinoma: In the literature, certain immunoregulatory subtypes of NK cells (CD3-CD16-CD56+)are reported to be associated with pathologically aggressive thyroid cancer (37), however, the main immune effector subtype of NK cells have been shown to clear cancerous cells with low MHC expression.